Fortress Biotech Inc banner

Fortress Biotech Inc
F:CNB

Watchlist Manager
Fortress Biotech Inc Logo
Fortress Biotech Inc
F:CNB
Watchlist
Price: 4.131 EUR Market Closed
Market Cap: €554.9m

Wall St Price Targets

CNB Price Targets Summary
Fortress Biotech Inc

Wall Street analysts forecast CNB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNB is 18.874 EUR with a low forecast of 7.823 EUR and a high forecast of 30.724 EUR.

Lowest Forecast
Price Target
7.823 EUR
89% Upside
Average Forecast
Price Target
18.874 EUR
357% Upside
Highest Forecast
Price Target
30.724 EUR
644% Upside
Fortress Biotech Inc Competitors:
Price Targets
AYTU
Aytu Biopharma Inc
285% Upside
AMSF
Amerisafe Inc
26% Upside

Revenue
Forecast

N/A
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate for Revenue over the next 2 years is 48%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CNB's stock price target?
Price Target
18.874 EUR

According to Wall Street analysts, the average 1-year price target for CNB is 18.874 EUR with a low forecast of 7.823 EUR and a high forecast of 30.724 EUR.

What is the Revenue forecast for Fortress Biotech Inc?
Projected CAGR
48%

The compound annual growth rate for Revenue over the next 2 years is 48%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett